MedPath

Effects of Time of Sleep Restriction in Obesity

Completed
Conditions
Obesity
Sleep Restriction
Appetite Regulation
Eating
Registration Number
NCT01259895
Lead Sponsor
Federal University of São Paulo
Brief Summary

The purpose of this study is to determine the effect of different time of sleep restriction on control of food intake and metabolism of obese and normal subjects.

Detailed Description

The reduction of sleep time has now become a common habit, driven by the demands and opportunities of modern society. Some studies have suggested that sleep restriction would be an important factor in predisposing to obesity. However studies of sleep restriction in obese individuals have not yet been conducted. Still, the time of sleep restriction varies greatly between studies, making it difficult to compare results.

The investigators aim to recruit 20 young adults, 10 obese and 10 normal weight individuals. The study will be conducted as a randomized, crossover study with three conditions. Each participant will be subjected to reduction of the beginning of sleep (from 3-7h), reduction of the end of sleep (from 23-3h), and normal sleep (from 23-7h), in random order, for three consecutive nights.

In each condition, subjects will stay for 4 days in the laboratory. Three control meals will be offered. Visual analogue scales will be applied before and after each meal to assess hunger and appetite for different food categories. Blood samples will be collected hourly during 24 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • obese (BMI>30) and normal weight (BMI between 19 and 24,9)
  • regular time of sleep between 6.5 and 8 hours
Exclusion Criteria
  • self-reported sleep problems (Pittsburgh Sleep Quality Index score >5);
  • Obstructive sleep apnea (AHI > 5 in polysomnography)
  • night work;
  • variable sleep habits or habitual daytime naps;
  • regular physical exercise (>3 hours/week);
  • excessive intake of alcohol (>7 drinks/week);
  • excessive intake of caffeine (>300 mg/day);
  • smoking;
  • substance abuse;
  • use of prescription medications or over-the-counter drugs affecting sleep or metabolism;
  • chronic diseases (e.g. cancer, asthma, back pain, thyroid disease, heart disease, diabetes, etc.)
  • history of neurological, medical or sleep disorders;
  • trans-meridian travelling the last month;
  • chronotype: extreme morning or extreme evening
  • unable to comply with the protocol.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Appetite regulating hormones and stress hormonesMeasured every hour over the course of 24 hours on day 3

Hormones are sampled from blood

Secondary Outcome Measures
NameTimeMethod
Hunger and satietyMeasured every 4 hour over the course of 12 hours on day 2 and 3

Hunger and saciety are measured using visual analogue scales before and after breakfast, lunch and dinner meal

Food intakemeasured each meal

The meal will be weighted before and after the breakfast, lunch and dinner. Energy and nutrient intake are assessed from the amount of the meal consumed.

Trial Locations

Locations (1)

Centro de Estudos em Psicobiologia e Exercicio (CEPE)

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath